No association between symptom severity and MMN impairment in schizophrenia: A meta-analytic approach.

Erickson, Molly A; Albrecht, Matthew; Ruffle, Abigail; Fleming, Leah; Corlett, Philip; Gold, James

Erickson, Molly A; Albrecht, Matthew; Ruffle, Abigail; Fleming, Leah; Corlett, Philip; Gold, James.

Afiliação

Erickson MA; University Behavioral Healthcare, Rutgers University, 671 Hoes Lane West, Piscataway, NJ 08854, United States.
Albrecht M; Maryland Psychiatric Research Center, University of Maryland, 55 Wade Avenue, Catonsville, MD 21228, United States.
Ruffle A; School of Public Health, Curtin University, GPO Box U1987, Perth, WA 6845, Australia.
Fleming L; Maryland Psychiatric Research Center, University of Maryland, 55 Wade Avenue, Catonsville, MD 21228, United States.
Corlett P; Interdepartmental Neuroscience Program, Yale University, 34 Park Street, New Haven, CT, 06519, United States.
Gold J; Department of Psychiatry, Yale University; 34 Park Street, New Haven, CT, 06519, United States.

Schizophr Res Cogn ; 9: 13-17, 2017 Sep.

Article em En | MEDLINE | ID: mdl-28740829

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Schizophr Res Cogn Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google